RAMP1

From WikiMD's Food, Medicine & Wellness Encyclopedia

RAMP1 (Receptor Activity Modifying Protein 1) is a protein that in humans is encoded by the RAMP1 gene. It is a crucial component in the biology of the human body, particularly in the field of medicine and pharmacology.

Function[edit | edit source]

RAMP1 is a member of the RAMP family of single-transmembrane-domain proteins, called receptor (calcitonin) activity modifying proteins (RAMPs). RAMPs are type I transmembrane proteins with an extracellular N terminus. These proteins are and are capable of interacting with G protein-coupled receptors (GPCRs).

RAMP1 is able to modify the function of several different G protein-coupled receptors, including the calcitonin receptor gene-related peptide (CGRP) receptor. This receptor is a heterodimer composed of the calcitonin receptor-like receptor (CLR) and RAMP1, which is required for functional expression of the CLR.

Clinical significance[edit | edit source]

Alterations in RAMP1 function have been associated with various medical conditions. For example, mutations in the RAMP1 gene have been linked to migraines, suggesting a role for this protein in the pathophysiology of this condition. Additionally, RAMP1 has been implicated in the regulation of blood pressure and heart rate, and may play a role in cardiovascular disease.

Research[edit | edit source]

Research into RAMP1 is ongoing, with studies focusing on its role in various physiological and pathological processes. This includes research into its role in the regulation of vascular tone, its potential as a therapeutic target for the treatment of migraines, and its involvement in cardiovascular disease.

See also[edit | edit source]

References[edit | edit source]



This GPCR-related article is a stub. You can help WikiMD by expanding it.


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD